ID   AGT2_HUMAN              Reviewed;         514 AA.
AC   Q9BYV1; B7ZM47; E9PDL7; Q53FB4; Q53FY7; Q53G03; Q5W7Q1;
DT   05-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   12-APR-2017, entry version 137.
DE   RecName: Full=Alanine--glyoxylate aminotransferase 2, mitochondrial;
DE            Short=AGT 2;
DE            EC=2.6.1.44;
DE   AltName: Full=(R)-3-amino-2-methylpropionate--pyruvate transaminase;
DE            EC=2.6.1.40;
DE   AltName: Full=Beta-ALAAT II;
DE   AltName: Full=Beta-alanine-pyruvate aminotransferase;
DE   AltName: Full=D-AIBAT;
DE   Flags: Precursor;
GN   Name=AGXT2; Synonyms=AGT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Jenne D.E.;
RT   "The human ortholog for rat alanine-glyoxylate aminotransferase 2.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANTS ASN-102; ILE-140
RP   AND ILE-212.
RA   Matsuda K., Horikawa Y., Kaneko M., Sakata S., Tamaki N.;
RT   "Human beta-alanine-pyruvate aminotransferase cDNA.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ASN-102; ILE-140; ILE-212 AND LEU-498.
RC   TISSUE=Kidney;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ASN-102 AND ILE-212.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION, TRANSIT PEPTIDE CLEAVAGE
RP   SITE, AND SUBCELLULAR LOCATION.
RX   PubMed=20018850; DOI=10.1074/jbc.M109.091280;
RA   Rodionov R.N., Murry D.J., Vaulman S.F., Stevens J.W., Lentz S.R.;
RT   "Human alanine-glyoxylate aminotransferase 2 lowers asymmetric
RT   dimethylarginine and protects from inhibition of nitric oxide
RT   production.";
RL   J. Biol. Chem. 285:5385-5391(2010).
RN   [7]
RP   FUNCTION.
RX   PubMed=23023372; DOI=10.1161/ATVBAHA.112.254078;
RA   Caplin B., Wang Z., Slaviero A., Tomlinson J., Dowsett L.,
RA   Delahaye M., Salama A., Wheeler D.C., Leiper J.;
RT   "Alanine-Glyoxylate aminotransferase-2 metabolizes endogenous
RT   methylarginines, regulates NO, and controls blood pressure.";
RL   Arterioscler. Thromb. Vasc. Biol. 32:2892-2900(2012).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   VARIANT ILE-140.
RX   PubMed=24834905;
RA   Zhou J.P., Bai Y.P., Hu X.L., Kuang D.B., Shi R.Z., Xiong Y.,
RA   Zhang W., Xia J., Chen B.L., Yang T.L., Chen X.P.;
RT   "Association of the AGXT2 V140I polymorphism with risk for coronary
RT   heart disease in a Chinese population.";
RL   J. Atheroscler. Thromb. 21:1022-1030(2014).
RN   [10]
RP   VARIANTS ILE-140 AND LEU-498, FUNCTION, SUBCELLULAR LOCATION, AND
RP   CHARACTERIZATION VARIANT ILE-140.
RX   PubMed=24586340; DOI=10.1371/journal.pone.0088544;
RA   Kittel A., Muller F., Konig J., Mieth M., Sticht H., Zolk O.,
RA   Kralj A., Heinrich M.R., Fromm M.F., Maas R.;
RT   "Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have
RT   considerable impact on methylarginine and beta-aminoisobutyrate
RT   metabolism in healthy volunteers.";
RL   PLoS ONE 9:E88544-E88544(2014).
CC   -!- FUNCTION: Can metabolize asymmetric dimethylarginine (ADMA) via
CC       transamination to alpha-keto-delta-(NN-dimethylguanidino) valeric
CC       acid (DMGV). ADMA is a potent inhibitor of nitric-oxide (NO)
CC       synthase, and this activity provides mechanism through which the
CC       kidney regulates blood pressure. {ECO:0000269|PubMed:20018850,
CC       ECO:0000269|PubMed:23023372, ECO:0000269|PubMed:24586340}.
CC   -!- CATALYTIC ACTIVITY: L-alanine + glyoxylate = pyruvate + glycine.
CC   -!- CATALYTIC ACTIVITY: (R)-3-amino-2-methylpropanoate + pyruvate = 2-
CC       methyl-3-oxopropanoate + L-alanine.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC   -!- SUBUNIT: Homotetramer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000269|PubMed:20018850,
CC       ECO:0000269|PubMed:24586340}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BYV1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BYV1-2; Sequence=VSP_055802;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the class-III pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ292204; CAC24841.1; -; mRNA.
DR   EMBL; AB193309; BAD66662.1; -; mRNA.
DR   EMBL; AK223128; BAD96848.1; -; mRNA.
DR   EMBL; AK223144; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK223375; BAD97095.1; -; mRNA.
DR   EMBL; AC010368; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC144268; AAI44269.1; -; mRNA.
DR   EMBL; BC150603; AAI50604.1; -; mRNA.
DR   CCDS; CCDS3908.1; -. [Q9BYV1-1]
DR   CCDS; CCDS78000.1; -. [Q9BYV1-2]
DR   RefSeq; NP_001293102.1; NM_001306173.1. [Q9BYV1-2]
DR   RefSeq; NP_114106.1; NM_031900.3. [Q9BYV1-1]
DR   RefSeq; XP_016865237.1; XM_017009748.1. [Q9BYV1-2]
DR   UniGene; Hs.34494; -.
DR   ProteinModelPortal; Q9BYV1; -.
DR   SMR; Q9BYV1; -.
DR   BioGrid; 122342; 2.
DR   IntAct; Q9BYV1; 2.
DR   STRING; 9606.ENSP00000231420; -.
DR   DrugBank; DB00145; Glycine.
DR   DrugBank; DB00160; L-Alanine.
DR   DrugBank; DB00114; Pyridoxal Phosphate.
DR   DrugBank; DB00119; Pyruvic acid.
DR   iPTMnet; Q9BYV1; -.
DR   PhosphoSitePlus; Q9BYV1; -.
DR   BioMuta; AGXT2; -.
DR   DMDM; 17432913; -.
DR   PaxDb; Q9BYV1; -.
DR   PeptideAtlas; Q9BYV1; -.
DR   PRIDE; Q9BYV1; -.
DR   Ensembl; ENST00000231420; ENSP00000231420; ENSG00000113492. [Q9BYV1-1]
DR   Ensembl; ENST00000510428; ENSP00000422799; ENSG00000113492. [Q9BYV1-2]
DR   Ensembl; ENST00000618015; ENSP00000479154; ENSG00000113492. [Q9BYV1-2]
DR   GeneID; 64902; -.
DR   KEGG; hsa:64902; -.
DR   UCSC; uc003jjf.4; human. [Q9BYV1-1]
DR   CTD; 64902; -.
DR   DisGeNET; 64902; -.
DR   GeneCards; AGXT2; -.
DR   HGNC; HGNC:14412; AGXT2.
DR   HPA; HPA037382; -.
DR   MIM; 612471; gene.
DR   neXtProt; NX_Q9BYV1; -.
DR   OpenTargets; ENSG00000113492; -.
DR   PharmGKB; PA24634; -.
DR   eggNOG; KOG1404; Eukaryota.
DR   eggNOG; COG0160; LUCA.
DR   GeneTree; ENSGT00530000062907; -.
DR   HOGENOM; HOG000020206; -.
DR   HOVERGEN; HBG004196; -.
DR   InParanoid; Q9BYV1; -.
DR   KO; K00827; -.
DR   OMA; LRHVECI; -.
DR   OrthoDB; EOG091G06LW; -.
DR   PhylomeDB; Q9BYV1; -.
DR   TreeFam; TF105945; -.
DR   BioCyc; MetaCyc:HS03685-MONOMER; -.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-73621; Pyrimidine catabolism.
DR   ChiTaRS; AGXT2; human.
DR   GenomeRNAi; 64902; -.
DR   PRO; PR:Q9BYV1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000113492; -.
DR   CleanEx; HS_AGXT2; -.
DR   Genevisible; Q9BYV1; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0047305; F:(R)-3-amino-2-methylpropionate-pyruvate transaminase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008453; F:alanine-glyoxylate transaminase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IBA:GO_Central.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IBA:GO_Central.
DR   GO; GO:0019265; P:glycine biosynthetic process, by transamination of glyoxylate; IDA:BHF-UCL.
DR   GO; GO:0009436; P:glyoxylate catabolic process; IDA:BHF-UCL.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0019481; P:L-alanine catabolic process, by transamination; IDA:BHF-UCL.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IDA:BHF-UCL.
DR   CDD; cd00610; OAT_like; 1.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR005814; Aminotrans_3.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_sub2.
DR   Pfam; PF00202; Aminotran_3; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
DR   PROSITE; PS00600; AA_TRANSFER_CLASS_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Aminotransferase;
KW   Complete proteome; Direct protein sequencing; Mitochondrion;
KW   Polymorphism; Pyridoxal phosphate; Reference proteome; Transferase;
KW   Transit peptide.
FT   TRANSIT       1     41       Mitochondrion.
FT                                {ECO:0000269|PubMed:20018850}.
FT   CHAIN        42    514       Alanine--glyoxylate aminotransferase 2,
FT                                mitochondrial.
FT                                /FTId=PRO_0000001269.
FT   MOD_RES      71     71       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES      71     71       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES      84     84       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES     262    262       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES     262    262       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES     304    304       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES     350    350       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   MOD_RES     417    417       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES     417    417       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES     420    420       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   MOD_RES     420    420       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q3UEG6}.
FT   VAR_SEQ     321    395       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055802.
FT   VARIANT     102    102       S -> I (in dbSNP:rs37370).
FT                                /FTId=VAR_061006.
FT   VARIANT     102    102       S -> N (in dbSNP:rs37370).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_023483.
FT   VARIANT     102    102       S -> T (in dbSNP:rs37370).
FT                                /FTId=VAR_061007.
FT   VARIANT     132    132       G -> R (in dbSNP:rs16870794).
FT                                /FTId=VAR_048231.
FT   VARIANT     140    140       V -> I (polymorphism; associated with an
FT                                increased risk for coronary heart disease
FT                                (CHD) in smoker and diabetic mellitus
FT                                (DM) patients in a Chinese population;
FT                                higher plasma symmetric (SDMA)
FT                                dimethylarginine as well as plasma and
FT                                urinary beta-aminoisobutyrate (BAIB)
FT                                concentrations; localized to the
FT                                mitochondrion as the wild-type; reduces
FT                                alanine-glyoxylate aminotransferase
FT                                activity; dbSNP:rs37369).
FT                                {ECO:0000269|PubMed:24586340,
FT                                ECO:0000269|PubMed:24834905,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_022140.
FT   VARIANT     212    212       T -> I (in dbSNP:rs180749).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.3}.
FT                                /FTId=VAR_022141.
FT   VARIANT     492    492       P -> R (in dbSNP:rs17245714).
FT                                /FTId=VAR_048232.
FT   VARIANT     498    498       V -> L (polymorphism; higher plasma and
FT                                urinary beta-aminoisobutyrate (BAIB)
FT                                concentrations; dbSNP:rs16899974).
FT                                {ECO:0000269|PubMed:24586340,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_029513.
SQ   SEQUENCE   514 AA;  57156 MW;  CA562F84FF39B5AC CRC64;
     MTLIWRHLLR PLCLVTSAPR ILEMHPFLSL GTSRTSVTKL SLHTKPRMPP CDFMPERYQS
     LGYNRVLEIH KEHLSPVVTA YFQKPLLLHQ GHMEWLFDAE GSRYLDFFSG IVTVSVGHCH
     PKVNAVAQKQ LGRLWHTSTV FFHPPMHEYA EKLAALLPEP LKVIFLVNSG SEANELAMLM
     ARAHSNNIDI ISFRGAYHGC SPYTLGLTNV GTYKMELPGG TGCQPTMCPD VFRGPWGGSH
     CRDSPVQTIR KCSCAPDCCQ AKDQYIEQFK DTLSTSVAKS IAGFFAEPIQ GVNGVVQYPK
     GFLKEAFELV RARGGVCIAD EVQTGFGRLG SHFWGFQTHD VLPDIVTMAK GIGNGFPMAA
     VITTPEIAKS LAKCLQHFNT FGGNPMACAI GSAVLEVIKE ENLQENSQEV GTYMLLKFAK
     LRDEFEIVGD VRGKGLMIGI EMVQDKISCR PLPREEVNQI HEDCKHMGLL VGRGSIFSQT
     FRIAPSMCIT KPEVDFAVEV FRSALTQHME RRAK
//
